Prevalence, Awareness, Treatment, and Control of Hypertension in China

Abstract—The objective of this study was to estimate the prevalence and distribution of hypertension and to determine the status of hypertension awareness, treatment, and control in the general adult population in China. The International Collaborative Study of Cardiovascular Disease in ASIA (InterASIA), conducted in 2000–2001, used a multistage cluster sampling method to select a nationally representative sample. A total of 15 540 adults, age 35 to 74 years, were examined. Three blood pressure measurements were obtained by trained observers by use of a standardized mercury sphygmomanometer after a 5-minute sitting rest. Information on history of hypertension and use of antihypertensive medications was obtained by use of a standard questionnaire. Hypertension was defined as a mean systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, and/or use of antihypertensive medications. Overall, 27.2% of the Chinese adult population age 35 to 74 years, representing 129 824 000 persons, had hypertension. The age-specific prevalence of hypertension was 17.4%, 28.2%, 40.7%, and 47.3% in men and 10.7%, 26.8%, 38.9%, and 50.2% in women age 35 to 44 years, 45 to 54 years, 55 to 64 years, and 65 to 74 years, respectively. Among hypertensive patients, only 44.7% were aware of their high blood pressure, 28.2% were taking antihypertensive medication, and 8.1% achieved blood pressure control (<140/90 mm Hg). Our results indicate that hypertension is highly prevalent in China. The percentages of those with hypertension who are aware, treated, and controlled are unacceptably low. These results underscore the urgent need to develop national strategies to improve prevention, detection, and treatment of hypertension in China.

[1]  M. Joffres,et al.  Awareness, treatment, and control of hypertension in Canada. , 1997, American journal of hypertension.

[2]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[3]  Zheng-lai Wu,et al.  Stroke in the People's Republic of China. II. Meta-analysis of hypertension and risk of stroke. , 1995, Stroke.

[4]  W. Yeh,et al.  Prevalence, awareness, treatment and control of hypertension in Taiwan: results of Nutrition and Health Survey in Taiwan (NAHSIT) 1993–1996 , 2001, Journal of Human Hypertension.

[5]  J. S. Kim,et al.  Hypertension in Korea: a national survey. , 1994, American journal of preventive medicine.

[6]  Z. Li,et al.  Blood pressure, cholesterol, and stroke in eastern Asia , 1998, The Lancet.

[7]  H. Gerstein,et al.  The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. , 1997, Archives of internal medicine.

[8]  Alan D. Lopez,et al.  Mortality by cause for eight regions of the world: Global Burden of Disease Study , 1997, The Lancet.

[9]  A. Rodgers,et al.  Blood pressure and the global burden of cardiovascular disease. , 1999, Clinical and experimental hypertension.

[10]  P. Whelton,et al.  Factors associated with hypertension control in the general population of the United States. , 2002, Archives of internal medicine.

[11]  G. Oláiz,et al.  Hypertension in urban Mexico: The 1992–93 national survey of chronic diseases , 1999, Journal of Human Hypertension.

[12]  R. Weinshilboum,et al.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. , 1997, Archives of internal medicine.

[13]  P. Whelton,et al.  Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.

[14]  C. Maynard Understanding racial differences in the use of thrombolytic therapy: what more do we need to know? , 1999, American heart journal.

[15]  National Center for Health Statistics. Vital and Health Statistics , 1969 .

[16]  B. Morgenstern,et al.  Human blood pressure determination by sphygmomanometry. , 1993, Circulation.

[17]  J. He Comparison of secular trends in prevalence of hypertension in the People's Republic of China (PRC) and the United States of America (USA). , 1996 .

[18]  Alan D. Lopez,et al.  Assessing the burden of mortality from cardiovascular diseases. , 1993, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[19]  P. Whelton,et al.  Selection of initial antihypertensive drug therapy , 2000, The Lancet.

[20]  N. Poulter,et al.  Improved Hypertension Management and Control: Results From the Health Survey for England 1998 , 2001, Hypertension.

[21]  Jing Liu,et al.  Sino-MONICA Project: A Collaborative Study on Trends and Determinants in Cardiovascular Diseases in China, Part I: Morbidity and Mortality Monitoring , 2001, Circulation.

[22]  B. Popkin,et al.  Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: the economic costs of the nutrition transition. , 2009, Nutrition reviews.

[23]  P. Whelton,et al.  Hypertension prevalence, awareness, treatment, and control in Egypt: Results from the Egyptian National Hypertension Project (NHP) , 1995 .

[24]  J. Cutler,et al.  Statement from the National High Blood Pressure Education Program: prevalence of hypertension. , 2000, American journal of hypertension.

[25]  P. Whelton,et al.  Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. , 1999, American heart journal.

[26]  Xi-gui Wu,et al.  Prevalence of hypertension and its trends in Chinese populations. , 1995, International journal of cardiology.

[27]  P. Whelton,et al.  Chapter 23 – Blood Pressure Reduction , 2004 .

[28]  P Whelton,et al.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.

[29]  T. Yipintsoi,et al.  Prevalence of coronary heart disease and major cardiovascular risk factors in Thailand. , 1998, International journal of epidemiology.

[30]  Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. , 1994, Vital and health statistics. Ser. 1, Programs and collection procedures.